On March 8th, several listed companies released favorable announcements.
1. Kales Group Passes Listing Hearing in Hong Kong According to Livermore Securities, Zhejiang Kales Technology Group Co., Ltd. has updated its post-hearing application materials, indicating the company has passed the Hong Kong Stock Exchange IPO hearing.
2. Jiangyin Zhongnan Heavy Industries to Acquire 57.3% Stake in Jiangsu Sulong Thermal Power; Trading Resumes Tomorrow Jiangyin Zhongnan Heavy Industries Co.,Ltd. (002445.SZ) announced its plan to acquire a 57.30% equity stake in Jiangsu Sulong Thermal Power Co., Ltd. from Jiangyin Electric Power Investment Co., Ltd. through a combination of issuing shares and paying cash. The company also plans to raise supporting funds from no more than thirty-five specific investors. The audit and evaluation work related to this transaction has not yet been completed, and the transaction plan requires further demonstration and negotiation. This transaction is expected to constitute a significant asset reorganization. Upon completion, the listed company's business footprint in the power energy sector will be expanded. Furthermore, the company will leverage its strengths in industrial metal pipe fitting manufacturing to enhance sales expansion in the power sector, increase brand awareness and product market share, and further strengthen its machinery manufacturing business segment. Upon application to the Shenzhen Stock Exchange, the company's stock will resume trading on Monday, March 9, 2026.
3. Gem Co.,Ltd. Signs Strategic Cooperation Agreement with China ENFI to Jointly Promote Critical Mineral Resource Development Gem Co.,Ltd. (002340.SZ) announced that it has signed a strategic cooperation agreement with China ENFI Engineering Co., Ltd. The two parties will deepen strategic cooperation in the development of critical mineral resources, their green, low-carbon, and efficient utilization, and global layout. This agreement aims to enhance the global competitiveness of Chinese enterprises and provide solid support for safeguarding national strategic security of critical mineral resources, achieving technological self-reliance, and promoting high-quality development. The agreement is valid until December 31, 2030.
4. Kingfa Technology Issues Open Letter Late at Night, Plans Price Increases for Some Products Kingfa Technology published a letter to customers on its official WeChat account. Due to the impact of the Middle East situation, global crude oil supply is tight, and oil prices and logistics costs are rising, leading to a sharp increase in industry costs. Consequently, the company will raise prices for some of its products. Simultaneously, the company commits to transparent and prudent price adjustments, with increases matching cost rises, avoiding excessive profits, and providing advance notice to allow customers planning time.
5. Haisco Pharmaceutical Group's Subsidiary Receives Acceptance Notice for Marketing Application of Innovative Drug HSK39297 Tablets Haisco Pharmaceutical Group Co.,Ltd. (002653.SZ) announced that its subsidiary, Sichuan Haisco Pharmaceutical Co., Ltd., recently received the Acceptance Notice for the marketing application of the innovative drug HSK39297 Tablets from the National Medical Products Administration. HSK39297 Tablets are indicated for the treatment of adult patients with paroxysmal nocturnal hemoglobinuria (PNH). This drug is a small-molecule inhibitor of complement factor B (FB) independently developed by the company. It works by inhibiting FB activity to block the amplification loop of the complement system, thereby inhibiting the activity of the entire complement pathway. Compared to eculizumab, HSK39297 Tablets show significant therapeutic advantages in improving anemia, reducing transfusion needs, and alleviating fatigue symptoms, with efficacy that can be maintained long-term. According to China's new chemical drug registration classification, this drug is classified as a Category 1 chemical drug. Haisco stated that due to the long review cycle, multiple stages, and associated uncertainties, investors are advised to make prudent decisions and be aware of investment risks.
Comments